Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Treasury Shares: 2009-2025

Historic Treasury Shares for BIO-TECHNE (TECH) over the last 16 years, with Jun 2025 value amounting to $831,000.

  • BIO-TECHNE's Treasury Shares rose 67.20% to $831,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $831,000, marking a year-over-year increase of 67.20%. This contributed to the annual value of $831,000 for FY2025, which is 67.20% up from last year.
  • BIO-TECHNE's Treasury Shares amounted to $831,000 in FY2025, which was up 67.20% from $497,000 recorded in FY2024.
  • Over the past 5 years, BIO-TECHNE's Treasury Shares peaked at $831,000 during FY2025, and registered a low of $283,000 during FY2023.
  • In the last 3 years, BIO-TECHNE's Treasury Shares had a median value of $497,000 in 2024 and averaged $537,000.
  • Per our database at Business Quant, BIO-TECHNE's Treasury Shares fell by 20.94% in 2022 and then soared by 75.62% in 2024.
  • BIO-TECHNE's Treasury Shares (Yearly) stood at $382,000 in 2021, then declined by 20.94% to $302,000 in 2022, then declined by 6.29% to $283,000 in 2023, then soared by 75.62% to $497,000 in 2024, then soared by 67.20% to $831,000 in 2025.